Fig. 3From: Optimization and scale up of microfluidic nanolipomer production method for preclinical and potential clinical trialsNanolipomer formulation parameters. a Effect of PLGA and DSPE-PEG concentration on the size and PDI of nanolipomers. b Nanolipomer stability assay at 4 °C over 1 week. c Effect of initial curcumin concentration on size and PDI. d Curcumin encapsulation efficiency and drug loading at various initial concentrations of curcumin. (n = 3: mean ± SD)Back to article page